About St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
During the past decade, St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
2010-03-01
2012-06-01
Completed
525
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
According to Clinical.Site data, the most researched conditions in "St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe" are
"Breast Cancer" (4 trials), "Breast Neoplasms" (1 trials), "Metastatic Breast Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe" in a lesser frequency.
Clinical Trials Intervention Types at St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
Most popular intervention types in "St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Pertuzumab" (4 trials), "Placebo" (4 trials), "Trastuzumab" (3 trials), "Docetaxel" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
The vast majority of trials in "St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe" are
6 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
Currently, there are NaN active trials in "St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".